There's plenty of research that can be done on why I am fundamentally holding this long term. It's getting into zones I am comfortable adding to the position. There are outside forces that have kept this stock beaten down for many years as they are the major big tobacco killer, as a micro-cap. My outlook is that when the switch flips and tides turn, this stock can be explosive, and the 10 year pennant has big upside.
Recent direct offering done at 2.05, currently 1.60. The long term equilibrium zone is roughly 1.40-1.70, I am a buyer, adding slowly here, and will continue to add sub 1.30.
The last year and a half the stock has been trading in a downward channel. Looking at previous 1-2 year periods, there are larger scale macro patterns that tend to form and play out.
Recent progress and development of their company key driving force in VLN, has become more and more a reality. Despite the company being in a great position after years of the rigorous FDA process, it's the final stretch for them as their product is now on shelves.
Pair that with being on the lower end of the range here, with earnings coming up and an update on their pilot program, I am adding to the long holds.
Roughly 7 years I've been following this company closely, swing trading it up and down. The recent direct offering with warrants gave investors the opportunity to short, but I believe it will be a short-lived downturn. The time horizon is 12 months for a macro reversal here to break the channel.
Recent direct offering done at 2.05, currently 1.60. The long term equilibrium zone is roughly 1.40-1.70, I am a buyer, adding slowly here, and will continue to add sub 1.30.
The last year and a half the stock has been trading in a downward channel. Looking at previous 1-2 year periods, there are larger scale macro patterns that tend to form and play out.
Recent progress and development of their company key driving force in VLN, has become more and more a reality. Despite the company being in a great position after years of the rigorous FDA process, it's the final stretch for them as their product is now on shelves.
Pair that with being on the lower end of the range here, with earnings coming up and an update on their pilot program, I am adding to the long holds.
Roughly 7 years I've been following this company closely, swing trading it up and down. The recent direct offering with warrants gave investors the opportunity to short, but I believe it will be a short-lived downturn. The time horizon is 12 months for a macro reversal here to break the channel.